• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

AJMC® in the Press, March 24, 2017


Coverage of our peer-reviewed research in the healthcare and mainstream press.

The American Pharmacists Association shared an article discussing a study published in the March issue of The American Journal of Managed Care® (AJMC®). In “Impact of a Pharmacy-Based Transitional Care Program on Hospital Readmissions,” researchers determined that a pharmacist intervention program reduced 30-day and 180-day readmission rates by 28% and 31.9%, respectively, compared with usual care after discharge. "The evidence is clear that community-based pharmacists can reduce health costs," said study author Jeffrey McCombs, PhD, in the American Pharmacists Association’s news release. The research was also highlighted in an article from Science Daily.

Amid ongoing efforts to repeal the Affordable Care Act (ACA), the March issue of AJMC® included an article that examined whether the access and quality of care had improved after the law’s implementation. The study, “Improvements in Access and Care Through the Affordable Care Act,” was summarized by PatientEngagementHIT.com. “Overall, the researchers found that the ACA has increased the number of patients who are visiting a regular primary care physician, being encouraged to quit smoking, and who feel confident in having a provider to visit in a medical emergency,” it concluded.

The recent AJMC® supplement issue, “Beyond Charitable Illness: Sustainable Strategies for Providing Access to Critical Medications,” included an article about specialty drug access under Medicare Part D titled “Reducing Out-of-Pocket Cost Barriers to Specialty Drug Use Under Medicare Part D: Addressing the Problem of ‘Too Much Too Soon’” that was highlighted in a number of publications. Specialty Pharmacy Times, Science Daily, and Youth Health all published articles discussing the study’s findings and proposed policy solutions.

An article published by Pacific Standard, “The Promise and Peril of Free-Market Health-Care Reform,” referenced an AJMC® study on the effects of high-deductible and consumer-driven health plans. According to the Pacific Standard article, “a team of researchers affiliated with RAND, a think tank that analyzes policies and programs, found that families who enrolled in these plans for the first time spent 14 percent less than families on traditional insurance plans.” The AJMC® study, “Healthcare Spending and Preventive Care in High-Deductible and Consumer-Driven Health Plans,” was published in 2011.

Related Videos
David Andorsky, MD, Rocky Mountain Cancer Center
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology
Video 7 - "Future Opportunities in Genitourinary Cancers"
Video 6 - "LITESPARK-003 Trial Insights: Updates from ESMO 2023"
Video 5 - "Key Highlights from EV-302 Study at ESMO 2023"
Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.
Andrew Srisuwananukorn, MD
Dr Jennifer Brown
Related Content
© 2023 MJH Life Sciences
All rights reserved.